Sinopharm Group Co., Ltd.

Pharmaceuticals
China
Earnings Per Share Growth (%)22.52%
Cost of Goods Sold (US$ Millions)$32,096
Current Liabilities (US$ Millions)$14,579
Total Assets (US$ Millions)$17,977
Long Term Debt$94
Return on Equity13.73%
Revenue (US$ Millions)$34,963
Total Company Assets$21,290
Revenue Growth (%)13.46%
Net Income (US$ Millions)$579
Earnings Per Share (US$)$22.52
Total Equity (US$ Millions)$4,627
Profit Margin (%)1.66%
Debt To Equity Ratio (%)0.02%
Inventory Turnover$3,441